Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Obsidian in Anastomotic Healing After Rectal Cancer Resection: A Prospective Clinical Feasibility Study

NCT05293054 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT05293054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Obsidian in Anastomotic Healing After Rectal Cancer Resection: A Prospective Clinical Feasibility Study
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Completed
Start date
December 15, 2021
Completion date
November 8, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anastomotic leak rectum, anastomotic leakage, rectal cancer